Omada Health published an independent model estimating up to $11,142 in gross medical cost savings per member over five years for its GLP-1 program.
- Five-year savings rose to $11,142 with 12-month medication persistence versus $8,578 with six-month persistence, implying about 30% higher value.
- Higher lifestyle engagement projected $9,739 in five-year savings versus $7,848 for lower engagement.
- The model projected 49% lower new-onset type 2 diabetes risk and 28% lower new-onset hypertension risk over five years versus standard care.
- The analysis cited 12.4% average weight loss at 12 months from nearly 25,000 GLP-1 Care Track members.